Refine
Year of publication
Document Type
- Preprint (682)
- Article (496)
- Conference Proceeding (2)
- Book (1)
- Other (1)
Has Fulltext
- yes (1182)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- Mammakarzinom (6)
- breast cancer (6)
- ALICE experiment (4)
- Behandlung (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Studien (4)
- trials (4)
- ALICE (3)
- COVID-19 (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- chemotherapy (3)
- pp collisions (3)
- Antimicrobial treatment (2)
- Atomic force microscopy (2)
- Beauty production (2)
- Biofilm (2)
- Brownian dynamics simulation (2)
- CDK4/6 (2)
- Cancer genomics (2)
- Charm physics (2)
- Complications (2)
- Deep brain stimulation (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Lokalrezidiv (2)
- Low-virulent infection (2)
- MRI (2)
- MRT (2)
- Mamma (2)
- Metastasen (2)
- Molecular dynamics simulation (2)
- Nachsorge (2)
- PD1/PDL1 (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Prävention (2)
- QCD (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Risiko (2)
- Single electrons (2)
- Single molecule force spectroscopy (2)
- Sonication (2)
- Tomosynthese (2)
- Ultraschall (2)
- biodiversity protection (2)
- breast (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- diagnosis (2)
- follow‑up (2)
- galactography (2)
- galactomosynthesis (2)
- global change (2)
- guideline (2)
- immune reconstitution (2)
- local recurrence (2)
- long non-coding RNA (2)
- macrophage polarization (2)
- malignancy (2)
- post-2020 biodiversity targets (2)
- predictive factors (2)
- prevention (2)
- primary immunodeficiency (2)
- prognostic factors (2)
- risk (2)
- screening (2)
- strategic site selection (2)
- tomosynthesis (2)
- treatment (2)
- treatment/therapy (2)
- ultrasound (2)
- von Willebrand factor (2)
- 900 GeV (1)
- ADAM15 (1)
- ALICE detector (1)
- ARDS (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Air traffic (1)
- Allogeneic hematopoietic stem (1)
- Anandamide (1)
- Anti-nuclei (1)
- Antihormone therapy (1)
- Aquaporins (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Ataxia-telangiectasia (1)
- Atherosclerosis (1)
- Auditory system (1)
- BTC (1)
- Bacteria-host interaction (1)
- Bacterial adhesion (1)
- Bidirectional genes (1)
- Biodiversity Data (1)
- Biomonitoring (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Bromodomänen (1)
- CCL2 (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- COVID (1)
- CRISPR/Cas9 (1)
- CVD biomarker (1)
- CYBA/p22phox (1)
- Cancer (1)
- Cancer genetics (1)
- Cardiomyopathy (1)
- Cardiovascular diseases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Chemische Sonden (1)
- Chimerism (1)
- Cleanliness level (1)
- Clinical study (1)
- Clinical trial (1)
- Collective Flow, (1)
- Colon capsule endoscopy (1)
- Colorectal cancer (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complex I (1)
- Consensus statement (1)
- Conservation (1)
- Critical care (1)
- Depression (1)
- Desinfektion von Flugzeugen (1)
- Diatoms (1)
- Digitization (1)
- Disinfection of aircraft (1)
- D’Amico classification (1)
- E/I-Balance (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryotoxicity (1)
- Emotions (1)
- Endometrial cancer (1)
- Endothelium (1)
- Epigenetics (1)
- Epigenetik (1)
- Europe (1)
- Experimental models of disease (1)
- Extracellular matrix (1)
- Falciparum (1)
- FcpA (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Fibronectin (1)
- Forschung (1)
- GVHD (1)
- Gamma-Band Activity (1)
- Gene expression (1)
- Genetic testing (1)
- Genomic instability (1)
- Germany (1)
- Gleason score (1)
- Glioblastoma (1)
- HBT (1)
- HDAC4 (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HNO (1)
- HOTAIR (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Health policy (1)
- Health risk analysis (1)
- Heart transplantation (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Herbaria (1)
- Heregulin (1)
- Hif1α (1)
- Highly infectious diseases (1)
- His-tag (1)
- Hochansteckende Krankheiten (1)
- Human behaviour (1)
- Human prostate (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Inflammation (1)
- Influenza (1)
- Intensity interferometry (1)
- Intestinal barrier (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Italy (1)
- JAWSTAT pathway (1)
- Jet Physics (1)
- Jet Substructure (1)
- KCNQ4 (1)
- LHRH receptor (1)
- Lactic acidosis (1)
- Lehre (1)
- Liver cirrhosis (1)
- Low volume prep (1)
- Luftverkehr (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MALAT1 (1)
- MGMT (1)
- MM-121 (1)
- Malaria (1)
- Material budget (1)
- Medizinische Chemie (1)
- Membrane protein (1)
- Mental health and psychiatry (1)
- Mesenchymal stem cells (1)
- Metastatic (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitochondrial disorder (1)
- Mixed hearing loss (1)
- Molecular medicine (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-endpoint toxicity study (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Myocardial infarction (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NCoR1 (1)
- NK cell (1)
- NK cell subset (1)
- NSAIDs (1)
- Nano- and microplastics (1)
- Nanodisc (1)
- Neonatal (1)
- Neural network (1)
- Neuroscience (1)
- Nuclear modification factor (1)
- ORL (1)
- Obesity (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Outcome (1)
- PD-1 (1)
- PD-L1 (1)
- PDGFRβ (1)
- PYTHIA (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Phase 2 (1)
- Phospho-soda (1)
- PillCamColon2 (1)
- Placental barrier (1)
- Plasmodium (1)
- Pneumonia (1)
- Polyps (1)
- Polystyrene (1)
- Portal hypertension (1)
- Pre-emptive immunotherapy (1)
- Primary hemostasis (1)
- Primary prophylaxis (1)
- Production Cross Section (1)
- Produkte zur Desinfektion (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostate cancer (1)
- Prostate cancer cell lines (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Psychometrics (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Questionnaires (1)
- Quinine (1)
- RNA PT (1)
- RNA modification (1)
- Rapidity Range (1)
- Red blood cell transfusion (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Research (1)
- Research Article (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance assignment (1)
- Respiratory syncytial virus (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCT (1)
- SIRT1 (1)
- SNP (1)
- STAT3 (1)
- SUV (1)
- Schizophrenia (1)
- Semantics (1)
- Seribantumab (1)
- Severe malaria (1)
- Single muons (1)
- Single-cell RNA-seq (1)
- Solution-state NMR (1)
- Sorafenib (1)
- Specialist training (1)
- Spontaneous bacterial peritonitis (1)
- Standardized operating procedures (1)
- Standardverfahren (1)
- Stroke (1)
- Strukturbasiertes Design (1)
- Substances for disinfection (1)
- Superinfection (1)
- Surgery (1)
- Sweden (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TR (1)
- TRPV4 (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Temozolomide (1)
- Thrombosis (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Treatment (1)
- Trigger (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper respiratory tract infection (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vector Boson Production (1)
- Vitamin (1)
- Weiterbildung (1)
- Xenon-based gas mixture (1)
- accident (1)
- adult (1)
- advanced breast cancer (1)
- agaricomycetes (1)
- allogeneic stem cell transplantation (1)
- anaemia (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- anti-angiogenic therapy (1)
- antifungals (1)
- antihormone therapy (1)
- ataxia telangiectasia (1)
- biodiversity (1)
- biologicals (1)
- bortezomib (1)
- brain metastases (1)
- bromodomains (1)
- c-kit (1)
- cancer (1)
- cancer surveillance (1)
- cascade model (1)
- cell proliferation (1)
- cell transplantation (1)
- cerebrospinal fluid (1)
- chemical probes (1)
- children (1)
- clinical trial (1)
- cochlea (1)
- combined immunodeficiency (1)
- community ecology (1)
- cross-linking (1)
- dE/dx (1)
- dental implants (1)
- detector (1)
- digestion artifact (1)
- discomfort/pain (1)
- dynamic 18F-FDG PET/CT (1)
- ecological networks (1)
- ecosystem functioning (1)
- ecosystem services (1)
- elderly patients (1)
- epigenetics (1)
- experimental results (1)
- functional connectivity (1)
- geriatric medicine (1)
- glioblastoma (1)
- heavy ion experiments (1)
- human (1)
- human knockout model (1)
- human well-being (1)
- induction regimen (1)
- injury (1)
- inverse stage migration (1)
- iron metabolism (1)
- kidney (1)
- kidney function (1)
- knockout mouse (1)
- lapatinib (1)
- lenalidomide (1)
- leukopenia (1)
- lockdown (1)
- long-term protection (1)
- long36 term protection (1)
- magnetic resonance imaging (1)
- magnetoencephalography (1)
- mass spectrometry (1)
- mechanotransduction (1)
- medicinal chemistry (1)
- medulloblastoma (1)
- metastases (1)
- metastasis (1)
- metastatic (1)
- multiple myeloma (1)
- neural oscillations (1)
- neutralizing antibodies (1)
- neutropenia (1)
- nucleoside analysis (1)
- pancreatic cancer (1)
- pannexin-1 (1)
- pazopanib (1)
- pediatric intensive care (1)
- periodontal probing, (1)
- peri‐implant probing (1)
- pertuzumab (1)
- photosynthesis (1)
- platform switching (1)
- polyacetylenes (1)
- polyines (1)
- polymeric micelle (1)
- polymorphism (1)
- polypept(o)ide (1)
- polyynes (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- prognosis (1)
- prostate cancer (1)
- quark gluon plasma (1)
- radical prostatecomy (1)
- radio sensitivity (1)
- radiotherapy (1)
- randomized (1)
- renal failure (1)
- risk factor progression (1)
- risk factors (1)
- schizophrenia (1)
- social-ecological system (1)
- soft tissue sarcoma (STS) (1)
- species identity (1)
- spectra (1)
- spike protein (1)
- stroke (1)
- structure-based design (1)
- subgrouping (1)
- superparamagnetic iron oxide nanoparticles (1)
- surgery (1)
- targeted therapy (1)
- therapy resistance (1)
- thylakoid (1)
- trastuzumab (1)
- trauma (1)
- tumor angiogenesis (1)
- tumor-infiltrating lymphocytes (1)
- two-tissue compartment model (1)
- variants of concern (1)
- xenograft (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1072)
- Frankfurt Institute for Advanced Studies (FIAS) (957)
- Informatik (921)
- Medizin (79)
- Biowissenschaften (11)
- Senckenbergische Naturforschende Gesellschaft (6)
- Biochemie und Chemie (4)
- Pharmazie (4)
- Georg-Speyer-Haus (3)
- Informatik und Mathematik (3)
The p300/CBP‐associated factor (PCAF) and related GCN5 bromodomain‐containing lysine acetyl transferases are members of subfamily I of the bromodomain phylogenetic tree. Iterative cycles of rational inhibitor design and biophysical characterization led to the discovery of the triazolopthalazine‐based L‐45 (dubbed L‐Moses) as the first potent, selective, and cell‐active PCAF bromodomain (Brd) inhibitor. Synthesis from readily available (1R,2S)‐(−)‐norephedrine furnished L‐45 in enantiopure form. L‐45 was shown to disrupt PCAF‐Brd histone H3.3 interaction in cells using a nanoBRET assay, and a co‐crystal structure of L‐45 with the homologous Brd PfGCN5 from Plasmodium falciparum rationalizes the high selectivity for PCAF and GCN5 bromodomains. Compound L‐45 shows no observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell‐permeability, and metabolic stability in human and mouse liver microsomes, supporting its potential for in vivo use.
Previous research indicates that anxiety disorders are characterized by an overgeneralization of conditioned fear as compared with healthy participants. Therefore, fear generalization is considered a key mechanism for the development of anxiety disorders. However, systematic investigations on the variance in fear generalization are lacking. Therefore, the current study aims at identifying distinctive phenotypes of fear generalization among healthy participants. To this end, 1175 participants completed a differential fear conditioning phase followed by a generalization test. To identify patterns of fear generalization, we used a k-means clustering algorithm based on individual arousal generalization gradients. Subsequently, we examined the reliability and validity of the clusters and phenotypical differences between subgroups on the basis of psychometric data and markers of fear expression. Cluster analysis reliably revealed five clusters that systematically differed in mean responses, differentiation between conditioned threat and safety, and linearity of the generalization gradients, though mean response levels accounted for most variance. Remarkably, the patterns of mean responses were already evident during fear acquisition and corresponded most closely to psychometric measures of anxiety traits. The identified clusters reliably described subgroups of healthy individuals with distinct response characteristics in a fear generalization test. Following a dimensional view of psychopathology, these clusters likely delineate risk factors for anxiety disorders. As crucial group characteristics were already evident during fear acquisition, our results emphasize the importance of average fear responses and differentiation between conditioned threat and safety as risk factors for anxiety disorders.